KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $686,000 | -30.4% | 49,232 | -11.8% | 0.00% | -33.3% |
| Q4 2020 | $986,000 | -76.6% | 55,826 | -79.7% | 0.00% | -80.0% |
| Q3 2020 | $4,220,000 | +132.5% | 275,444 | +286.7% | 0.02% | +66.7% |
| Q2 2020 | $1,815,000 | +523.7% | 71,225 | +279.1% | 0.01% | +350.0% |
| Q1 2020 | $291,000 | +44.8% | 18,789 | +3.2% | 0.00% | +100.0% |
| Q4 2019 | $201,000 | -41.4% | 18,211 | +35.5% | 0.00% | 0.0% |
| Q3 2018 | $343,000 | – | 13,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |